North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity

July 2022 | 100 pages | ID: N788C22F2D38EN
GMD Research

Abstracts

North America pharmaceutical analytical testing outsourcing market is projected to grow by 7.5% annually in the forecast period and reach $ 6,029.2 million by 2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities.

Highlighted with 24 tables and 47 figures, this 100-page report “North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America pharmaceutical analytical testing outsourcing market in every aspect of the classification from perspectives of Service Type, Product Type, End User, Organization Size, and Country.

Based on Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Bioanalytical Testing
• Clinical Testing
• Non-clinical Testing
• Method Development and Validation
• Extractable & Leachable
• Impurity Method
• Technical Consulting
• Other Methods
• Stability Testing
• Drug Substances Testing
• Accelerated Stability Testing
• Photostability Testing
• Other Stability Testings
• Other Services

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Raw Materials & Additives
• Active Pharmaceutical Ingredients (APIs)
• Finished Products

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Other End Users

By Organization Size, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• SMEs
• Large Enterprises

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Service Type, End User and Organization Size over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Boston Analytical, Inc.

Charles River Laboratories International, Inc.

Eurofins Scientific SE

Exova Group PLC

Intertek Pharmaceutical Services

Laboratory Testing Inc.

Pace Analytical Services LLC

Pharmaceutical Product Development, LLC

SGS SA

Steris PLC

Tentamus

Toxikon Inc.

West Pharmaceutical Services Inc.

WuXi AppTec, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY SERVICE TYPE

3.1 Market Overview by Service Type
3.2 Bioanalytical Testing
  3.2.1 Clinical Testing
  3.2.2 Non-clinical Testing
3.3 Method Development and Validation
  3.3.1 Extractable & Leachable
  3.3.2 Impurity Method
  3.3.3 Technical Consulting
  3.3.4 Other Methods
3.4 Stability Testing
  3.4.1 Drug Substances Testing
  3.4.2 Accelerated Stability Testing
  3.4.3 Photostability Testing
  3.4.4 Other Stability Testings
3.5 Other Services

4 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT TYPE

4.1 Market Overview by Product Type
4.2 Raw Materials & Additives
4.3 Active Pharmaceutical Ingredients (APIs)
4.4 Finished Products

5 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Contract Manufacturing Organizations (CMOs)
5.4 Other End Users

6 SEGMENTATION OF NORTH AMERICA MARKET BY ORGANIZATION SIZE

6.1 Market Overview by Organization Size
6.2 SMEs
6.3 Large Enterprises

7 NORTH AMERICA MARKET 2021-2031 BY COUNTRY

7.1 Overview of North America Market
7.2 U.S.
7.3 Canada
7.4 Mexico

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
Boston Analytical, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Exova Group PLC
Intertek Pharmaceutical Services
Laboratory Testing Inc.
Pace Analytical Services LLC
Pharmaceutical Product Development, LLC
SGS SA
Steris PLC
Tentamus
Toxikon Inc.
West Pharmaceutical Services Inc.
WuXi AppTec, Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of North America Pharmaceutical Analytical Testing Outsourcing Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. Worldwide Total Number of Registered Clinical Trials
Table 4. Main Product Trends and Market Opportunities in North America Pharmaceutical Analytical Testing Outsourcing Market
Table 5. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn
Table 6. North America Pharmaceutical Analytical Testing Outsourcing Market: Bioanalytical Testing by Type, 2021-2031, $ mn
Table 7. North America Pharmaceutical Analytical Testing Outsourcing Market: Method Development and Validation by Type, 2021-2031, $ mn
Table 8. North America Pharmaceutical Analytical Testing Outsourcing Market: Stability Testing by Type, 2021-2031, $ mn
Table 9. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type, 2021-2031, $ mn
Table 10. North America Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn
Table 11. North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn
Table 12. North America Pharmaceutical Analytical Testing Outsourcing Market by Country, 2021-2031, $ mn
Table 13. U.S. Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn
Table 14. U.S. Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn
Table 15. U.S. Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn
Table 16. Canada Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn
Table 17. Canada Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn
Table 18. Canada Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn
Table 19. Mexico Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn
Table 20. Mexico Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn
Table 21. Mexico Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn
Table 22. Boston Analytical, Inc.: Company Snapshot
Table 23. Boston Analytical, Inc.: Business Segmentation
Table 24. Boston Analytical, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. North America Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America Pharmaceutical Analytical Testing Outsourcing Market
Figure 7. World Pharmaceutical CDMO Market, 2019-2030, $ bn
Figure 8. World Drug Discovery Market, 2019-2030, $ mn
Figure 9. Primary Restraints and Impact Factors of North America Pharmaceutical Analytical Testing Outsourcing Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of North America Pharmaceutical Analytical Testing Outsourcing Market
Figure 12. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, % of Revenue
Figure 13. North America Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%)
Figure 14. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Bioanalytical Testing, 2021-2031, $ mn
Figure 15. North America Pharmaceutical Analytical Testing Outsourcing Market by Bioanalytical Testing: Clinical Testing, 2021-2031, $ mn
Figure 16. North America Pharmaceutical Analytical Testing Outsourcing Market by Bioanalytical Testing: Non-clinical Testing, 2021-2031, $ mn
Figure 17. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Method Development and Validation, 2021-2031, $ mn
Figure 18. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Extractable & Leachable, 2021-2031, $ mn
Figure 19. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Impurity Method, 2021-2031, $ mn
Figure 20. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Technical Consulting, 2021-2031, $ mn
Figure 21. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Other Methods, 2021-2031, $ mn
Figure 22. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Stability Testing, 2021-2031, $ mn
Figure 23. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Drug Substances Testing , 2021-2031, $ mn
Figure 24. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Accelerated Stability Testing, 2021-2031, $ mn
Figure 25. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Photostability Testing, 2021-2031, $ mn
Figure 26. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Other Stability Testings, 2021-2031, $ mn
Figure 27. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Other Services, 2021-2031, $ mn
Figure 28. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type, 2021-2031, % of Sales Revenue
Figure 29. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)
Figure 30. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Raw Materials & Additives, 2021-2031, $ mn
Figure 31. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Active Pharmaceutical Ingredients (APIs), 2021-2031, $ mn
Figure 32. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Finished Products, 2021-2031, $ mn
Figure 33. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, % of Sales Revenue
Figure 34. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 35. North America Pharmaceutical Analytical Testing Outsourcing Market by End User: Pharmaceutical & Biopharmaceutical Companies, 2021-2031, $ mn
Figure 36. North America Pharmaceutical Analytical Testing Outsourcing Market by End User: Contract Manufacturing Organizations (CMOs), 2021-2031, $ mn
Figure 37. North America Pharmaceutical Analytical Testing Outsourcing Market by End User: Other End Users, 2021-2031, $ mn
Figure 38. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, % of Revenue
Figure 39. North America Addressable Market Cap in 2022-2031 by Organization Size, Value ($ mn) and Share (%)
Figure 40. North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size: SMEs, 2021-2031, $ mn
Figure 41. North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size: Large Enterprises, 2021-2031, $ mn
Figure 42. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Country, 2021 and 2031, % of Revenue
Figure 43. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 44. U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn
Figure 45. Canada Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn
Figure 46. Pharmaceutical Analytical Testing Outsourcing Market in Mexico, 2021-2031, $ mn
Figure 47. Growth Stage of North America Pharmaceutical Analytical Testing Outsourcing Industry over the Forecast Period